Assessment of serum visfatin levels in girls with anorexia nervosa

Clinical Endocrinology

Volumn 76, Issue 4, 2012, Pages 514-519

  Ziora, Katarzyna ^a   Oświȩcimska, Joanna ^a   Świȩtochowska, Elzbieta ^a   Ziora, Dariusz ^a   Stojewska, Małgorzata ^a   Suwała, Andrzej ^b   Ostrowska, Zofia ^a   Gorczyca, Piotr ^a   Klimacka Nawrot, Ewa ^a   Lukas, Witold ^a   Błońska Fajfrowska, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b IPSEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ARTICLE; BLOOD SAMPLING; BODY MASS; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; EATING DISORDER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ANOREXIA NERVOSA; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY;

EID: 84857853143     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04181.x     Document Type: Article

References (32)

1. Fukuhara, A., Matsuda, M., Nishizawa, M. et al. (2005) Visfatin: a protein secreted by visceral FAT that mimics the effect of insulin. Science, 307, 426-430. (Pubitemid 40139988)
2. Samal, B., Sun, Y., Stearns, G. et al. (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology, 14, 1431-1437.
3. Hug, C. & Lodish, H.F. (2005) Visfatin: a new adipokine. Science, 307, 366-371.
4. Revollo, J.R., Körner, A., Mills, K.F. et al. (2007) Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cellular Metabolism, 6, 363-375. (Pubitemid 350011996)
5. Lopez-Bermejo, A., Chico-Julia, B., Fernandez-Balsells, M. et al. (2006) Serum visfatin increases with progressive beta-cell deterioration. Diabetes, 55, 2871-2875. (Pubitemid 44923689)
6. Ünlütürk, U., Harmanci, A. & Yildiz. B.O., etal. (2010) Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women. Clinical Endocrinology, 72, 469-474.
7. Choi, K.M., Kim, J.H., Cho, G.J. et al. (2007) Effects of exercise training on plasma visfatin and eotaxin levels. European Journal of Endocrinology, 157, 437-442. (Pubitemid 350018446)
8. Haider, D.G., Schindler, K., Schaller, G. et al. (2006) Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. Journal of Clinical Endocrinology and Metabolism, 91, 1578-1581.
9. Zahorska-Markiewicz, B. (2006) Metabolic effects associated with adipose tissue distribution. Advances in Medical Sciences, 51, 111-114.
10. Zahorska-Markiewicz, B., Olszanecka-Glinianowicz, M., Janowska, J. et al. (2007) Serum concentration of visfatin in obese women. Metabolism, 56, 1131-1134. (Pubitemid 47021180)
11. Haider, D.G., Holzer, G., Schaller, G. et al. (2006) The adipokine visfatin is markedly elevated in obese children. Journal of Pediatric Gastroenterology and Nutrition, 43, 548-549. (Pubitemid 44569022)
12. Sun, G., Bishop, J., Khalili, S. et al. (2007) Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. American Journal of Clinical Nutrition, 85, 399-404. (Pubitemid 46220940)
13. De Luis, D.A., Gonzalez Sagrado, M., Cionde, R. et al. (2008) Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients. Nutrition, 24, 517-521.
14. Nogal, P. & Lewiński, A. (2008) Jadłowstrȩt psychiczny (anorexia nervosa). Endokrynologia Polska, 59, 148-155.
15. Dostálová, I., Sedláčková, D., Papežová, H. et al. (2008) Serum visfatin levels in patients with anorexia nervosa and bulimia nervosa. Physiological Research, 58, 903-907.
16. Palczewska, I. & Niedźwiecka, Z. (2001) Wskaźniki rozwoju somatycznego dzieci i młodzie-zy warszawskiej. Medycyna Wieku Rozwojowego, 2(Suppl. 1), 5-39.
17. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. text revision. APA, Washington, DC.
18. Berndt, J., Klöting, N., Kralisch, S. et al. (2005) Plasma visfatin concentrations and fat depot - specific mRNA expression in humans. Diabetes, 54, 2911-2916. (Pubitemid 41401086)
19. Chen, C.C., Li, T.C., Li, C.I. et al. (2007) The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. Metabolism - Clinical and Experimental, 56, 1216-1220.
20. Dogru, T., Sonmez, A., Tasci, I. et al. (2007) Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Research and Clinical Practice, 76, 24-29. (Pubitemid 46240362)
21. Korner, A., Garten, A., Bluher, M. et al. (2007) Molecular characteristics of serum visfatin and differential detection by immunoassays. Journal of Clinical Endocrinology and Metabolism, 92, 4783-4791.
22. Pagano, C., Pilon, C., Olivieri, M. et al. (2006) Reduced plasma visfatin/preB cell colony enhancing factor in obesity is not related to insulin resistance in humans. Journal of Clinical Endocrinology and Metabolism, 91, 3165-3170. (Pubitemid 44271773)
23. Wen, Y., Wang, H.W. & Wu J., etal. (2006) Effects of fatty acid regulation on visfatin gene expression in adipocytes. Chinese Medical Journal, 119, 1701-1708. (Pubitemid 44697234)
24. Haider, D.G., Mittermayer, F., Schaller, G. et al. (2006) Free fatty acids normalize a rosiglitazone-induced visfatin release. American Journal of Physiology Endocrinology and Metabolism, 291, E885-E890.
25. De Louis, D.A., Aller, R., Gonzalez Sagrado, M. et al. (2010) Serum visfatin concentrations are related to dietary intake in obese patients. Annals of Nutrition and Metabolism, 57, 265-270.
26. Prioletta, A., Muscogiuri, G., Sorice, G.P. et al. (2011) In anorexia nervosa, even a small increase of abdominal fat is responsible for the appearance of insulin resistance. Clinical Endocrinology (Oxford), 75, 202-206.
27. Reaven, G. (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
28. Samara, A., Pfister, M., Marie, B. et al. (2008) Visfatin, low-grade inflammation and BMI. Clinical Endocrinology (Oxford), 69, 568-574.
29. Li, L., Yang, G., Li, Q. et al. (2006) Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Experimental Clinical Endocrinology and Diabetes, 114, 544-548. (Pubitemid 46087259)
30. Rodríguez, G., Moreno, L.A., Blay, M.G. et al. (2004) Body composition in adolescents: measurements and metabolic aspects. International Journal of Obesity, 28, 54-58.
31. Marcinkowska, M., Lewandowski, K.C., Lewiński, A. et al. (2007) Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans. Endokrynologia Polska, 58, 188-194.
32. Varma, V., Yao-Borengasser, A., Rasouli, N. et al. (2007) Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids and inflammation. Journal of Clinical Endocrinology and Metabolism, 92, 666-672.